Truist Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.4M | Buy |
2,470,900
+67,026
| +3% | +$1.78M | 0.09% | 189 |
|
|
2025
Q4 | $59.9M | Sell |
2,403,874
-467,441
| -16% | -$11.8M | 0.08% | 213 |
|
|
2025
Q3 | $73.2M | Sell |
2,871,315
-23,328
| -0.8% | -$576K | 0.1% | 182 |
|
|
2025
Q2 | $70.2M | Sell |
2,894,643
-25,611
| -0.9% | -$597K | 0.1% | 186 |
|
|
2025
Q1 | $74M | Sell |
2,920,254
-50,714
| -2% | -$1.33M | 0.12% | 166 |
|
|
2024
Q4 | $78.8M | Sell |
2,970,968
-287,723
| -9% | -$7.8M | 0.12% | 159 |
|
|
2024
Q3 | $94.3M | Sell |
3,258,691
-183,861
| -5% | -$5.36M | 0.15% | 136 |
|
|
2024
Q2 | $96.3M | Sell |
3,442,552
-119,445
| -3% | -$3.29M | 0.15% | 142 |
|
|
2024
Q1 | $98.8M | Buy |
3,561,997
+258,510
| +8% | +$7.17M | 0.15% | 139 |
|
|
2023
Q4 | $95.1M | Sell |
3,303,487
-691,277
| -17% | -$20.9M | 0.15% | 137 |
|
|
2023
Q3 | $133M | Buy |
3,994,764
+74,746
| +2% | +$2.64M | 0.22% | 104 |
|
|
2023
Q2 | $144M | Sell |
3,920,018
-118,249
| -3% | -$4.6M | 0.24% | 99 |
|
|
2023
Q1 | $165M | Buy |
4,038,267
+4,204
| +0.1% | +$182K | 0.28% | 83 |
|
|
2022
Q4 | $207M | Buy |
4,034,063
+20,608
| +0.5% | +$988K | 0.36% | 68 |
|
|
2022
Q3 | $176M | Sell |
4,013,455
-416,742
| -9% | -$20.3M | 0.34% | 77 |
|
|
2022
Q2 | $232M | Sell |
4,430,197
-167,076
| -4% | -$8.51M | 0.43% | 55 |
|
|
2022
Q1 | $238M | Sell |
4,597,273
-189,521
| -4% | -$9.83M | 0.38% | 62 |
|
|
2021
Q4 | $283M | Sell |
4,786,794
-337,095
| -7% | -$16.7M | 0.43% | 59 |
|
|
2021
Q3 | $220M | Sell |
5,123,889
-311,861
| -6% | -$13.8M | 0.36% | 70 |
|
|
2021
Q2 | $213M | Buy |
5,435,750
+147,241
| +3% | +$5.73M | 0.35% | 70 |
|
|
2021
Q1 | $192M | Sell |
5,288,509
-19,018
| -0.4% | -$675K | 0.33% | 72 |
|
|
2020
Q4 | $195M | Sell |
5,307,527
-242,341
| -4% | -$8.89M | 0.37% | 63 |
|
|
2020
Q3 | $193M | Sell |
5,549,868
-352,855
| -6% | -$12.4M | 0.42% | 53 |
|
|
2020
Q2 | $183M | Sell |
5,902,723
-109,609
| -2% | -$3.72M | 0.41% | 55 |
|
|
2020
Q1 | $186M | Sell |
6,012,332
-437,135
| -7% | -$14.9M | 0.49% | 44 |
|
|
2019
Q4 | $240M | Buy |
6,449,467
+5,472,972
| +560% | +$195M | 0.49% | 43 |
|
|
2019
Q3 | $33.3M | Sell |
976,495
-46,370
| -5% | -$1.69M | 0.57% | 41 |
|
|
2019
Q2 | $42M | Sell |
1,022,865
-88,153
| -8% | -$3.5M | 0.73% | 30 |
|
|
2019
Q1 | $44.8M | Sell |
1,111,018
-57,884
| -5% | -$2.32M | 0.8% | 22 |
|
|
2018
Q4 | $48.4M | Sell |
1,168,902
-2,446
| -0.2% | -$102K | 0.99% | 19 |
|
|
2018
Q3 | $49M | Buy |
1,171,348
+138,449
| +13% | +$5.33M | 0.88% | 19 |
|
|
2018
Q2 | $35.6M | Sell |
1,032,899
-10,572
| -1% | -$361K | 0.68% | 30 |
|
|
2018
Q1 | $35.1M | Sell |
1,043,471
-4,168
| -0.4% | -$143K | 0.67% | 30 |
|
|
2017
Q4 | $36M | Sell |
1,047,639
-28,541
| -3% | -$973K | 0.67% | 30 |
|
|
2017
Q3 | $36.5M | Sell |
1,076,180
-9,072
| -0.8% | -$292K | 0.71% | 25 |
|
|
2017
Q2 | $34.6M | Sell |
1,085,252
-24,643
| -2% | -$777K | 0.69% | 26 |
|
|
2017
Q1 | $36M | Sell |
1,109,895
-80,168
| -7% | -$2.53M | 0.72% | 25 |
|
|
2016
Q4 | $36.7M | Sell |
1,190,063
-18,188
| -2% | -$555K | 0.75% | 25 |
|
|
2016
Q3 | $38.8M | Sell |
1,208,251
-38,852
| -3% | -$1.3M | 0.8% | 22 |
|
|
2016
Q2 | $41.7M | Sell |
1,247,103
-8,454
| -0.7% | -$270K | 0.88% | 18 |
|
|
2016
Q1 | $35.3M | Sell |
1,255,557
-88,100
| -7% | -$2.52M | 0.91% | 17 |
|
|
2015
Q4 | $41.2M | Sell |
1,343,657
-73,334
| -5% | -$2.31M | 1.07% | 13 |
|
|
2015
Q3 | $42.2M | Buy |
1,416,991
+374,998
| +36% | +$12M | 1.1% | 12 |
|
|
2015
Q2 | $33.1M | Buy |
1,041,993
+26,355
| +3% | +$859K | 0.9% | 15 |
|
|
2015
Q1 | $33.5M | Sell |
1,015,638
-81,943
| -7% | -$2.61M | 0.96% | 11 |
|
|
2014
Q4 | $32.4M | Sell |
1,097,581
-17,671
| -2% | -$507K | 0.95% | 14 |
|
|
2014
Q3 | $31.3M | Buy |
1,115,252
+6,488
| +0.6% | +$182K | 0.95% | 17 |
|
|
2014
Q2 | $31.2M | Buy |
1,108,764
+12,296
| +1% | +$351K | 0.94% | 14 |
|
|
2014
Q1 | $33.4M | Buy |
1,096,468
+2,710
| +0.2% | +$80.8K | 1.05% | 12 |
|
|
2013
Q4 | $31.8M | Sell |
1,093,758
-857
| -0.1% | -$24.9K | 1.02% | 13 |
|
|
2013
Q3 | $29.8M | Sell |
1,094,615
-21,703
| -2% | -$591K | 1.06% | 12 |
|
|
2013
Q2 | $29.7M | Buy |
+1,116,318
| New | +$30.8M | 1.1% | 11 |
|
Other funds holding PFE
VCM
VPM
Truist Financial's PFE Position: Q1 2026 in Review
Truist Financial increased its Pfizer (PFE) stake by 2.8% in Q1 2026, buying an estimated $1.78M and bringing the position to 2,470,900 shares worth $69.4M. The position accounts for 0.09% of the portfolio, ranked #189.
Truist Financial first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $283M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Truist Financial held 2,470,900 shares of Pfizer worth $69.4M as of Q1 2026.
- Truist Financial bought 67,026 Pfizer shares in Q1 2026, an estimated $1.78M.
- Pfizer made up 0.09% of Truist Financial's portfolio in Q1 2026, its #189 holding.
- Truist Financial first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Truist Financial's Pfizer position peaked at $283M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.